MarketsFN

Legence (LGN) Q3 2025 Financial Results Summary

· Stocks · QuoteReporter

Legence Corp. (LGN) Q3 2025 Financial Results Summary

Release Date: November 14, 2025

Legence Corp. reported its financial results for the third quarter ending September 30, 2025, showcasing impressive growth across various metrics compared to the same quarter in the previous year.

Key Financial Highlights:

Segment Performance:

Backlog and Awards:

Debt and Liquidity:

Guidance:

Acquisitions:

Dividends and Share Repurchase:

Summary:

Legence Corp. demonstrated robust growth in Q3 2025, with significant increases in revenue, Adjusted EBITDA, and backlog compared to the prior year. The company also highlighted a strategic acquisition process and significantly reduced its debt, positioning itself well for future growth.

Condensed Consolidated Statements of Operations

(In thousands, except per share data) (Unaudited)

2025 2024 2025 2024
Revenue 708,006 560,804 1,812,849 1,550,387
Cost of revenue 559,947 442,258 1,424,412 1,232,561
Gross profit 148,059 118,546 388,437 317,826
Selling, general and administrative 85,887 67,199 227,814 179,848
Depreciation and amortization 24,183 25,475 75,619 70,738
Acquisition-related costs 795 154 971 5,593
Loss (gain) on sale of property and equipment 21 -199
Equity in earnings of joint venture -24 -1,233 -848 -3,131
Income from operations 37,197 26,951 85,080 64,778
Interest expense 28,183 23,707 88,228 65,392
Interest income -1,069 -523 -2,588 -4,356
Loss on debt extinguishment 5,685 5,685
Credit agreement amendment fees 64 2,990 4,119
Other income, net -123 -121 -268 -434
Total other expense, net 32,740 23,063 94,047 64,721
Income (loss) before income tax 4,457 3,888 -8,967 57
Income tax expense 4,078 4,564 13,662 9,500
Net income (loss) 379 -676 -22,629 -9,443
Net income attributable to 955 407 4,430 407
Net loss attributable to Legence -576 -1,083 -27,059 -9,850
Net loss per Class A Common Stock—basic and diluted -0.02 -0.02
Weighted-average Class A Common Stock outstanding—basic and diluted 58,511

Condensed Consolidated Balance Sheets

(In thousands) (Unaudited)

September 30, 2025 December 31, 2024
Assets
Current assets:
Cash and cash equivalents 176,034 81,167
Accounts receivable, net 588,433 448,610
Contract assets, net 234,302 188,132
Prepaid expenses and other current assets 39,038 38,506
Total current assets 1,037,807 756,415
Property and equipment, net 81,094 73,381
Operating lease right-of-use assets, (including amounts from related parties) 106,469 90,922
Goodwill 782,931 781,194
Intangible assets, net 562,361 624,250
Other assets 29,607 26,338
Total assets 2,600,269 2,352,500
Liabilities and Equity
Current liabilities:
Accounts payable 224,256 126,502
Accrued compensation and benefits 89,832 54,601
Accrued and other current liabilities 25,659 28,490
Contract liabilities 285,894 164,130
Current portion of operating lease liabilities, (including amounts from related parties) 18,051 14,402
Current portion of long-term debt 16,301 22,984
Total current liabilities 659,993 411,109
Long-term debt, net of current portion, (including amounts from related parties) 812,628 1,585,846
Operating lease liabilities, net of current portion, (including amounts from related parties) 94,568 80,669
Tax receivable agreement liability – related party 146,474
Deferred tax liabilities, net 41,543 35,428
Other long-term liabilities 17,590 35,856
Total liabilities 1,772,796 2,148,908
Stockholders’ equity / Member’s equity
Member’s equity 443,738
Preferred stock
Class A common stock 585
Class B common stock 467
Additional paid-in capital 664,299
Accumulated deficit -277,228 -250,169
Accumulated other comprehensive (loss) income -248 9,111
Total Legence stockholders’ equity / Member’s equity 387,875 202,680
Noncontrolling interests 439,598 912
Total stockholders’ equity / Member’s equity 827,473 203,592
Total liabilities and stockholders’ equity / Member’s equity 2,600,269 2,352,500